APA (7th ed.) Citation

Di Gioia, D., Reichardt, P., Emre Güler, S., Ghani, S., Schuebbe, G., Berclaz, L., . . . Lindner, L. (2025). 2728P Initial clinical data confirm galenic principle and demonstrate therapeutic potential of THE001 (DPPG2-TSL-DOX) combined with regional hyperthermia (RHT) in soft tissue sarcoma (STS). Annals of Oncology, 36, S1451. https://doi.org/10.1016/j.annonc.2025.08.3338

Chicago Style (17th ed.) Citation

Di Gioia, D., et al. "2728P Initial Clinical Data Confirm Galenic Principle and Demonstrate Therapeutic Potential of THE001 (DPPG2-TSL-DOX) Combined with Regional Hyperthermia (RHT) in Soft Tissue Sarcoma (STS)." Annals of Oncology 36 (2025): S1451. https://doi.org/10.1016/j.annonc.2025.08.3338.

MLA (9th ed.) Citation

Di Gioia, D., et al. "2728P Initial Clinical Data Confirm Galenic Principle and Demonstrate Therapeutic Potential of THE001 (DPPG2-TSL-DOX) Combined with Regional Hyperthermia (RHT) in Soft Tissue Sarcoma (STS)." Annals of Oncology, vol. 36, 2025, p. S1451, https://doi.org/10.1016/j.annonc.2025.08.3338.